In clinical studies, therapeutic products being tested for safety and efficacy are classified as Medicinal Products (MP) or Medical Devices (MD). When a therapeutic product is under investigation in a study, it is referred to as the investigational MP or MD, abbreviated as IMP or IMD.
Table of contents
Definition of IMP
An Investigational Medicinal Product (IMP) is a pharmaceutical form of an active ingredient or placebo being tested or used as a reference in a clinical trial. This definition extends beyond newly developed compounds.
IMP Usage
The terms medicinal product (IMP), study drug, and experimental drug all refer to the product that is being investigated in a clinical trial to test either its safety or efficacy (or both) in humans.
Simple reconstitution or dilution of an IMP, including a sterile injection for the purpose of administration, falls outside the definition.
сегодня
Key Characteristics of IMPs
Several factors characterize an IMP:
- Pharmaceutical Form: IMPs are presented in a specific pharmaceutical form (e.g., tablet, capsule, injection) suitable for administration.
- Active Ingredient or Placebo: IMPs contain either an active ingredient intended to have a therapeutic effect or a placebo (an inactive substance used as a control).
- Testing or Reference: IMPs are either being tested for their potential therapeutic benefits or used as a reference product for comparison in a clinical trial.
- Clinical Trial Context: The crucial element is that the medicinal product is being used within the framework of a clinical trial, designed to gather data on its safety, efficacy, and other relevant properties.
Examples of IMPs
IMPs can encompass a wide range of medicinal products, including:
- New Chemical Entities: Novel compounds that have never been tested in humans before.
- Existing Marketed Products: Already approved drugs being investigated for a new indication, dosage regimen, or patient population.
- Generics: Generic versions of approved drugs being compared to the original brand-name product.
- Placebos: Inactive substances used as controls to assess the true effect of the active treatment.
Importance of IMPs in Clinical Research
IMPs are fundamental to the advancement of medical knowledge and the development of new treatments. Clinical trials involving IMPs are essential for:
- Evaluating Safety and Efficacy: Determining whether a potential new treatment is safe and effective for its intended use.
- Identifying Optimal Dosage: Establishing the most appropriate dose of a drug to achieve the desired therapeutic effect while minimizing side effects.
- Comparing Treatments: Assessing the relative benefits and risks of different treatments for a particular condition.
- Improving Patient Outcomes: Ultimately, leading to the development of new and improved therapies that enhance patient health and well-being.
The rigorous testing and evaluation of IMPs through well-designed clinical trials are critical for ensuring that new treatments are safe, effective, and beneficial for patients.
